It works by slowing gastric emptying, increasing feelings of satiety, and reducing hunger signals both in the gut and centrally in the brain
However, you should also be aware of the statutes of limitations that may apply to your case
SURPASS trials: type 2 diabetes data The SURPASS trial series examined tirzepatide versus semaglutide specifically in patients with type 2 diabetes
Again, not a bad thing, but something to be aware of
However, it has traditionally been believed that T2D drugs are more efficacious for subjects with higher HbA1C, partly due to the relief of the stress from glucotoxicity [24], and that is what we observed as well
The Wegovy labeling describes a stepwise dosage escalation, so the earliest weeks are spent below the maintenance dosage that generated the trial results